Spinocerebellar Ataxia Type 2

Neurology
1
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Arrowhead Pharmaceuticals
1 program
1
ARO-ATXN2 InjectionPhase 11 trial
Active Trials
NCT06672445Recruiting36Est. Dec 2026
Ionis Pharmaceuticals
1 program
Lumbar punctureN/A
Biogen
BiogenCAMBRIDGE, MA
1 program
Lumbar punctureN/A1 trial
Active Trials
NCT04288128Completed40Est. Jun 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Arrowhead PharmaceuticalsARO-ATXN2 Injection
BiogenLumbar puncture

Clinical Trials (2)

Total enrollment: 76 patients across 2 trials

NCT06672445Arrowhead PharmaceuticalsARO-ATXN2 Injection

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Start: Dec 2024Est. completion: Dec 202636 patients
Phase 1Recruiting
NCT04288128BiogenLumbar puncture

Integrated Functional Evaluation of the Cerebellum

Start: May 2020Est. completion: Jun 202240 patients
N/ACompleted

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
7h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
7h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
7h ago

Director of Finance

CoMind
London, UK
7h ago

Electronics Engineering Manager

CoMind
London, UK
7h ago

Director of Information Technology

Zavation Medical Products
7h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 76 patients
3 companies competing in this space

Related Indications

Multiple Sclerosis(274)Schizophrenia(255)Epilepsy(242)Parkinson Disease(171)Alzheimer's Disease(165)Parkinson's Disease(160)Alzheimer Disease(117)Stroke(102)Relapsing-Remitting Multiple Sclerosis(83)Depression(82)